
|Podcasts|July 19, 2021
OncView™ Podcast: Updates in Managing Extensive-Stage Small Cell Lung Cancer
Author(s)Benjamin Levy, MD, Matthew Fowler
This special edition of the “Oncology Peer Review On-The-Go” dives into recent updates and important treatment strategies for extensive-stage SCLC management.
Advertisement
As part of its OncView™ video series, CancerNetwork® spoke with Benjamin Levy, MD, of the John Hopkins Sidney Kimmel Comprehensive Cancer Center, to discuss frontline management of extensive-stage small cell lung cancer (SCLC) and the recent updates in the field.
In the video series, Levy discussed the following:
Small Cell Lung Cancer: Risk and Prognosis Small Cell Lung Cancer: Standard of Care Extensive-Stage Small Cell Lung Cancer: Gaps in Treatment Immunotherapy for First-Line Extensive-Stage SCLC First-Line I-O Plus Chemotherapy for Extensive-Stage SCLC Significance of the IMpower133 Trial in Extensive-Stage SCLC
To watch more videos in CancerNetwork®’s OncView™ series, visit
Don’t forget to subscribe to the "Oncology Peer Review On-The-Go" podcast wherever you get your podcasts.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Palbociclib Combo in HR+, HER2+ Metastatic Breast Cancer
2
NCCN Updates Bladder Cancer Guidelines for ctDNA MRD Testing
3
Zanzalintinib/Atezolizumab Misses Survival End Point in Non-MSI-H mCRC Subgroup
4
Sigvotatug Vedotin Does Not Significantly Improve Survival in NSCLC Trial
5




















































































